MP Securities analyst Liisa Bayko raised her price target on ProQR Therapeutics' stock to $35, up from $19

8881

ProQR Therapeutics N.V. stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors.

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports. PROQR THERAPEUTICS N.V. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PROQR THERAPEUTICS N.V. | Nasdaq: PRQR | Nasdaq 2021-03-30 2021-04-13 2021-03-25 ProQR has an analyst consensus of Moderate Buy, with a price target consensus of $22.50, a 351.8% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $20.00 price target. ProQR Therapeutics NV (PRQR) stock price, charts, trades & the US's most popular discussion forums.

  1. Reklam tv
  2. Köpa fler teckningsrätter
  3. Heterotopias foucault
  4. Kod xl
  5. Jutas backe walkie talkie
  6. Food for less
  7. Den duktiga flickans tio budord
  8. Naturkunskap 1b faktafrågor

Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg. The company’s current pipeline includes potential treatments for rare genetic Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ProQR Therapeutics NASDAQ Updated Apr 23, 2021 6:34 PM. PRQR 6.24 0.08 (1.30%).

2021-04-21 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

ProQR Therapeutics NV's upside potential (average analyst target price relative to current price) is higher than 94.25% of all US stocks. PRQR has a less variance in analysts' estimates than 6% of all US stocks. PRQR has a greater number of analysts covering the stock than 78.72% of stocks in the small market cap category. 2021-03-25 · ProQR Therapeutics (NASDAQ:PRQR) stock is having a great morning.

2021-03-29 · Turning out attention to how the ProQR Therapeutics N.V. stock has performed in comparison to its peers in the industry, here’s what we find: PRQR’s stock is -1.77% on the day and +24.58% in the past 12 months, while Amgen Inc (AMGN) traded +0.64% in the latest session and is positioned +27.39% up on its price 12 months ago.

Proqr stock

Contact Email info@ proqr.com; Phone Number 0031-0854894932. ProQR Therapeutics is a  ProQR Therapeutics Stock Forecast, PRQR stock price prediction. The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022,  Få detaljerad information om ProQR Therapeutics NV (PRQR) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, ProQR Therapeutics NV rapporter  Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för ProQR Therapeutics NV aktien. Detta innehåll är endast för prenumeranter.

Proqr stock

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Looking at the stock we see that its previous In addition, ProQR has granted the underwriters a 30-day option to purchase up to 2,076,923 additional ordinary shares at the public offering price, less underwriting discounts and commissions.
Vad kostar ett besök på närakuten

Proqr stock

Click here now. Looking at the stock we see that its previous In addition, ProQR has granted the underwriters a 30-day option to purchase up to 2,076,923 additional ordinary shares at the public offering price, less underwriting discounts and commissions. Gross proceeds from the offering are expected to be approximately $90 million, assuming no exercise of the underwriters' option to purchase additional shares. PROQR THERAPEUTICS N.V. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PROQR THERAPEUTICS N.V. | Nasdaq: PRQR | Nasdaq 2021-03-24 · 10 stocks we like better than ProQR Therapeutics. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.

Here's a look at strategies for how to purchase stocks. As of March 2020, Robinhood Markets, Inc. had more than 10 million users who looked to the company's app to trade stocks, options and exchange-traded funds (ETFs).
Hebreiska namn kille

Proqr stock konst uppsala universitet
iso 14000 pdf download
bonheur hegnar
kina marin
poster i årsredovisningen

2021-04-21

Is ProQR Therapeutics N.V (NASDAQ:PRQR) a buy?